Skip to main content
Padgett Medical Center

Recovery and healing ยท Peptide Therapy

BPC-157 in Tampa, FL

BPC-157 (Body Protection Compound-157) is a peptide that may support healing of tendons, ligaments and other injuries, and the stomach and intestinal lining. Most of the research is in animals, so a licensed provider goes over what is known before anything is prescribed.

Padgett Medical Center in Tampa, Florida offers BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon, prescribed after a free consultation with a licensed provider and compounded by a licensed U.S. compounding pharmacy.

  • The consultation is free. You only pay for your peptides if you start.
  • New patients: 10% off the first peptide order when you book online with a card on file
  • In person in Tampa or telehealth anywhere in Florida

BPC-157 at Padgett

From $275

Every product and price is listed below.

Consultation
Free
Form
An oral capsule or an injection
Prescribed by
A licensed provider
Compounded by
A licensed U.S. compounding pharmacy

Compounded peptides have not been approved by the FDA.

Pricing

BPC-157 price in Tampa

The consultation is free. You only pay for your peptides if you start. BPC-157 at Padgett Medical Center in Tampa costs $12 per capsule or $275 (injection, 1 vial, a month's supply).

BPC-157 prices at Padgett Medical Center, Tampa, FL
ProductOrderPriceCard on file10% off first order, new patients
CapsuleOral BPC-157Priced per capsule$12per capsule$10.80per capsule
InjectionOne vial1 vial, a month's supply$275$247.50

New patients who book online with a card on file get 10% off their first peptide order ($275 becomes $247.50). Nothing is charged when you book, and current patients pay the listed price.

Your provider confirms the right product at your consultation. Prices are subject to change. Compounded for you by a licensed U.S. compounding pharmacy: about our partner pharmacies.

Compounded peptides have not been approved by the FDA.

What is BPC-157?

BPC-157, short for Body Protection Compound-157 (also written BPC 157 or BPC157), is a lab-made peptide: a short chain of 15 amino acids. Its sequence comes from a larger protein first found in human stomach juice, which is why researchers call it a stable gastric pentadecapeptide. It is not a hormone or a steroid, and some research papers call it PL 14736.

BPC-157 is unusually stable in stomach acid, so researchers have studied it both by mouth and by injection. Once it reaches the bloodstream it breaks down quickly: animal studies put its half-life at under 30 minutes.

Who BPC-157 may help

BPC-157 may help with:

  • Healing of tendons, ligaments and other injuries
  • Tissue repair after a strain or injury
  • The stomach and intestinal lining, mainly as oral BPC-157
  • Healing of ulcers, based on animal studies of the stomach lining

These are possibilities, not promises. Most of the evidence comes from animal studies, and BPC-157 does not replace care for a diagnosed condition.

How BPC-157 may work

No one fully understands how BPC-157 works. FDA reviewers noted in 2026 that its molecular targets have not been identified. Lab and animal studies point to a few possible actions.

It appears to help new small blood vessels grow into injured tissue (angiogenesis), partly by raising levels of VEGFR2, a receptor for a key blood vessel growth signal. It also interacts with the nitric oxide system, which helps control blood flow and protects the lining of the stomach and intestines.

A 2025 systematic review found that it increases growth hormone receptor expression and pathways involved in cell growth, while lowering some inflammatory signals. In rat studies it protected the stomach and intestinal lining from damage caused by alcohol and by high doses of NSAID pain relievers.

What the research shows

What has been seen in cells and animals, what has been seen in people, and what has not been shown yet.

Lab and animal studies

Almost all BPC-157 research is in rats and mice. A 2025 systematic review in HSS Journal found 36 studies relevant to sports medicine, and 35 of them were preclinical. In those animal models, BPC-157 improved functional, structural and strength measures after muscle, tendon, ligament and bone injuries.

Other rat studies found it protected the stomach and intestinal lining and helped surgically created colon fistulas close, whether it was given by injection or in drinking water. These results are promising, but animal results often do not carry over to people, and FDA reviewers noted that no dose-response relationship has been established.

Studies in people

Human evidence is very limited. A 2026 systematic review in Acta Orthopaedica Belgica found only three small human studies, with 30 people in total and no comparison group in any of them: a chart review of 16 people who had knee injections (some combined with thymosin beta-4), most of whom reported less pain; a pilot study in 12 women with interstitial cystitis, most of whom reported their symptoms improved; and an IV safety pilot in 2 healthy adults with no reported side effects. The reviewers rated the certainty of this evidence as very low.

A 2005 placebo-controlled trial of BPC-157 enemas in people with ulcerative colitis was reported only as a meeting abstract, and FDA reviewers judged its data inadequate to show a benefit. No published human study has tested oral or under-the-skin BPC-157 for tendon, ligament or gut healing, and there are no published human data on how well oral BPC-157 is absorbed.

The bottom line

Animal research suggests BPC-157 may support tissue repair and the gut lining. It has not been shown to work in well-designed human trials.

BPC-157 is not FDA-approved. In July 2026 an FDA advisory committee voted 8 to 6, with 1 abstention, to recommend adding BPC-157 to the list of substances pharmacies may use in compounding. FDA staff had recommended against it, citing limited safety and effectiveness data. The vote is advisory.

How BPC-157 is taken

At Padgett, BPC-157 comes as an oral capsule or an injection. Your provider sets the dose; the general pattern for each product is below.

  • Capsule, Oral BPC-157Priced per capsule. By mouth, as your provider directs.
  • Injection, One vial1 vial, a month's supply. As your provider directs.

Oral forms are mostly of interest for the stomach and gut lining, because BPC-157 is unusually stable in stomach acid. No human study has compared oral and injected BPC-157 or published a measurement of how much oral BPC-157 the body absorbs.

If BPC-157 is right for you, your provider recommends a form and sets your dose and schedule at your consultation.

BPC-157 side effects and safety

Your provider reviews your health history and every medicine you take before prescribing.

Possible side effects

  • Redness or swelling at the injection site (injection only)
  • Headaches
  • Gas
  • Allergic reaction
  • Long-term effects in people are not yet known

Tell your provider about any new symptom, or call (813) 888-7710. In a medical emergency, call 911.

Who should not take BPC-157

  • People who are pregnant, trying to become pregnant, or breastfeeding (there are no human safety data, and animal reproductive testing is incomplete)
  • Anyone with active cancer, a history of cancer, or an undiagnosed lump or growth (a theoretical concern, because BPC-157 appears to promote new blood vessel growth)
  • Children and teens under 18 (not studied)
  • People with a bleeding or clotting disorder, or who take blood thinners, unless their provider approves it after review (blood clotting times changed in animal studies)
  • Competitive athletes subject to drug testing (prohibited at all times by the World Anti-Doping Agency)
  • Anyone who has had an allergic reaction to BPC-157 or any ingredient in the product

This is not a complete list. Your provider reviews your full health history before prescribing.

What is known about safety

There are too few human data to describe BPC-157's side effects with confidence. In 2026, FDA reviewers concluded there is not enough clinical safety information to characterize its safety profile, and there are no long-term human safety data. The small human studies reported no serious side effects. In healthy volunteers given BPC-157 as an enema, the most common complaints were headache and gas.

Through December 2025, FDA's adverse event database held three reports, all involving injected BPC-157: redness and swelling at the injection site; shortness of breath that led to an emergency room visit; and darkening of the skin and gums in a person using a "research use only" blend of BPC-157 and TB-500. It is unclear whether BPC-157 caused any of these.

In 28-day studies in rats and dogs, FDA noted changes in blood clotting times and in liver-related blood tests such as ALT. No cancer studies have been done, and reproductive testing is incomplete. Because BPC-157 appears to promote new blood vessel growth, and tumors also depend on new blood vessels, a 2025 review cautioned that it may not be a good choice for anyone who has, or may unknowingly have, cancer. This has not been studied in people.

FDA notes that injected or nasal peptides can trigger immune reactions, and that impurities or clumping of the peptide can raise that risk. BPC-157 is also on the World Anti-Doping Agency's 2026 Prohibited List (class S0), banned in and out of competition.

Medicines and interactions

No drug interaction studies have been done in people, so these concerns come from how BPC-157 acts in animals. It affects the nitric oxide system and changed blood clotting times in animal studies, so tell your provider if you take a blood thinner or antiplatelet medicine such as warfarin, apixaban, clopidogrel or daily aspirin. Because nitric oxide also affects blood vessels, reviewers advise extra care in people with heart or blood vessel disease.

In animal studies, BPC-157 affected dopamine and serotonin signaling, so mention antidepressants, stimulants and other psychiatric medicines. Avoid combining it with peptides or supplements from unverified sources, and tell your provider about every medicine and supplement you take.

TB-500 vs BPC-157

Both are studied for recovery and healing, and each is a separate product. No one has studied the two together in people, so your provider decides whether one, both or neither makes sense for you.

TB-500 vs BPC-157 at Padgett Medical Center, Tampa, FL
TopicTB-500BPC-157
Also calledThymosin Beta-4 fragment, TB500, TB 500Body Protection Compound-157, BPC 157, BPC157
Studied forMay support tissue repair, wound healing and muscle recovery.May support healing of tendons, ligaments and injuries, and the gut lining.
Forms at Padgettan injectionan oral capsule or an injection
Price$300$12 per capsule or $275
EvidenceThe biology of thymosin beta-4 and a small amount of animal research suggest TB-500 may support tissue repair, wound healing and muscle recovery. There is no human trial evidence for TB-500 itself.Animal research suggests BPC-157 may support tissue repair and the gut lining. It has not been shown to work in well-designed human trials.

Peptide quality

Prescribed and pharmacy-compounded, not "research grade"

At Padgett Medical Center in Tampa, peptides are prescribed only after a consultation with a licensed medical provider, and each one is compounded for the individual patient by a licensed U.S. compounding pharmacy. That is not the same as the "research grade" or "research use only" peptides sold online, which are labeled not for human use and are not made or checked to pharmacy standards for people, so there is no way to be sure of their strength, purity or sterility, or how well they will work.

Prescribed, pharmacy-compounded peptides at Padgett Medical Center compared with research-grade peptides sold online
Prescribed and pharmacy-compounded at PadgettResearch-grade / research use only
Who decides it's right for you
A licensed provider reviews your health history at a free consultation before anything is prescribed.No one. You pick a vial from a website.
Where it's made
A licensed U.S. compounding pharmacy, made for you to a prescription.Unknown manufacturers, often overseas, selling "for research use only".
Meant for people?
Yes. Compounded for a named patient to take.No. Labeled not for human use or consumption.
Strength, purity and sterility
Held to pharmacy compounding standards.Not verified to pharmacy standards, so the dose and what else is in the vial are unknown.
Support while you take it
Tell your provider about any side effect or question while you take it; they can adjust your plan.You're on your own.
Price
Published on every peptide page, and the consultation is free.Cheap per vial, but you can't know what you're paying for.

Regulatory status

Are these peptides FDA-approved? Where things stand in November 2026

No. BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon are not FDA-approved, and compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are prescribed.

On October 30, 2026, the U.S. Department of Health and Human Services (HHS) published a notice in the Federal Register about an interim policy for compounding these six peptides. It says HHS does not intend to take enforcement action against state-licensed pharmacies and licensed physicians that compound them for individual patients while the FDA completes formal rulemaking, as long as specific conditions are met. Those conditions include:

  • A prescription for each patient
  • A bulk ingredient from an FDA-registered manufacturer, tested for identity, purity, strength and contaminants
  • One peptide per product, so no blends
  • Only the forms the policy lists for each peptide (for example, Semax only as a nasal spray)
  • For forms taken by mouth, documentation that enough of the peptide is absorbed in people
  • Reporting serious side effects to the FDA

The policy is temporary and may change. The Federal Register notice announced it as a draft, open for public comment into mid-November 2026, so HHS may revise it, and HHS has said it may revisit it if safety or quality problems come up. The policy does not mean these peptides are proven safe or effective. It does not cover peptides sold as research chemicals or supplements.

Before it, in July 2026, an FDA advisory committee voted to recommend adding these six peptides to the list of substances pharmacies may compound from. FDA staff had recommended against it, citing limited human safety data, and the vote is advisory.

At Padgett Medical Center, peptides are prescribed only after a consultation with a licensed provider, and each one is compounded for you by a licensed U.S. compounding pharmacy.

Sources: Federal Register: notice of the HHS interim policy on 503A compounding of certain peptides, 91 FR 68526 (October 30, 2026), FR Doc. 2026-22192; Holland & Knight: HHS issues interim enforcement discretion policy for compounding of 6 peptides (November 4, 2026); FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (content current April 22, 2026); Healio: FDA committee recommends looser restrictions for several peptides (July 24, 2026).

BPC-157 questions, answered

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a lab-made peptide, a chain of 15 amino acids, based on a protein found in human stomach juice. Researchers have studied it for healing of tendons, ligaments, muscle and the gut lining. It may support tissue repair, but most of the research so far is in animals.

Does BPC-157 work in people?

It may, but well-designed human trials have not shown it yet. Almost all BPC-157 research is in rats and mice, where it improved healing of tendons, ligaments, muscle, bone and the gut lining. Only a few very small human studies exist, none with a comparison group, and reviewers rate that evidence as very low certainty. At your consultation, your provider goes over what is known and what is not before you decide.

Is BPC-157 FDA-approved?

No. BPC-157 is not FDA-approved for any use, and compounded peptides are not FDA-approved drugs. It has not been through the large trials the FDA uses to confirm that a drug is safe and effective. At Padgett, a licensed provider decides whether it is a reasonable option for you, and a licensed U.S. compounding pharmacy compounds it for you.

Is BPC-157 legal in Florida?

BPC-157 is not FDA-approved, so the answer depends on how it is made and prescribed. On October 30, 2026, the U.S. Department of Health and Human Services (HHS) published a notice in the Federal Register about an interim policy for BPC-157 and five other peptides. It says HHS does not intend to take enforcement action against state-licensed pharmacies and licensed physicians that compound them for individual patients while the FDA completes formal rulemaking, as long as conditions are met, including a prescription for each patient, a tested ingredient from an FDA-registered manufacturer and one peptide per product. For BPC-157, the policy covers injections under the skin or into a muscle and oral and topical forms, and an oral form also needs documented absorption in people. The policy does not cover products sold online as "research use only". It is temporary and may change, and Florida pharmacy and medical rules still apply. At Padgett Medical Center, BPC-157 is prescribed after a consultation with a licensed provider and compounded by a licensed U.S. compounding pharmacy.

Where can I get BPC-157 in Tampa?

At Padgett Medical Center, 6904 W. Linebaugh Ave, Tampa, FL 33625. You start with a free consultation with a licensed provider, in person at our Tampa clinic or by telehealth from anywhere in Florida. If BPC-157 is right for you, a licensed U.S. compounding pharmacy compounds it for you, and you only pay for it if you start.

Can I get a BPC-157 prescription online?

Your free consultation can be by telehealth from anywhere in Florida, or in person at our Tampa clinic. A licensed provider reviews your health history and medicines, and if BPC-157 is right for you, it is prescribed for you and compounded by a licensed U.S. compounding pharmacy. Padgett does not provide BPC-157 without a consultation.

Is BPC-157 banned in sports?

Yes. BPC-157 is on the World Anti-Doping Agency's Prohibited List, banned in and out of competition, so it is not for athletes who are drug tested.

Is oral BPC-157 different from the injection?

BPC-157 is unusually stable in stomach acid, which is why it can be taken by mouth. In rat studies, BPC-157 given in drinking water helped surgically created colon fistulas heal, and other rat studies found it protected the stomach and intestinal lining. That is why oral forms are mostly of interest for the gut. No human study has compared oral and injected BPC-157 or published a measurement of how much oral BPC-157 the body absorbs. If BPC-157 is right for you, your provider recommends a form.

What are the side effects of BPC-157?

Its side effects are not well known because it has had little testing in people. Small human studies reported no serious side effects. Reported problems include redness or swelling at the injection site, and headache and gas in a study of BPC-157 enemas. FDA has a few reports, including shortness of breath and skin darkening, but it is unclear whether BPC-157 caused them. Long-term effects are unknown, so tell your provider about any new symptom.

Can I take BPC-157 if I have had cancer?

Tell your provider about any cancer history before you start. BPC-157 appears to encourage new blood vessel growth, and tumors also rely on new blood vessels. Some researchers have cautioned that it may not be a good choice for anyone who has, or might have, cancer. This has not been studied in people. The cautious approach is to avoid BPC-157 if you have active cancer or a history of cancer, unless your oncologist and your provider agree.

How is Padgett's BPC-157 different from "research grade" BPC-157 sold online?

"Research grade" or "research use only" BPC-157 is labeled not for human use. It is not made or checked to pharmacy standards for people, so its strength, purity and sterility are unknown. Reviewers have warned that unregulated BPC-157 may be contaminated or mislabeled, and FDA found that most certificates of analysis for BPC-157 ingredients include only a purity test. At Padgett, BPC-157 is prescribed only after a consultation with a licensed provider, and a licensed U.S. compounding pharmacy compounds it for you. Research-grade vs pharmacy-compounded peptides explains the difference.

How much does BPC-157 cost?

The consultation is free, and nothing is charged when you book. You only pay for BPC-157 if you start it. BPC-157 at Padgett Medical Center in Tampa costs $12 per capsule or $275 (injection, 1 vial, a month's supply). New patients who book online with a card on file get 10% off their first peptide order ($275 becomes $247.50). Nothing is charged when you book, and current patients pay the listed price.

Free peptide consultation

Talk with a licensed provider about BPC-157

The consultation is free. You only pay for your peptides if you start. In person at our Tampa clinic or by telehealth anywhere in Florida, and new patients who book online with a card on file get 10% off their first peptide order.

Interested in more than one peptide? Pick them all when you book.

* Compounded peptides have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness or quality, and none of the peptides on this site is an FDA-approved drug. The benefits described are possibilities from research, not promises, and results vary from person to person. A licensed provider decides at your consultation whether a peptide is right for you. This page is educational and is not medical advice.

Call NowBook